Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
06/30/1993 | EP0548190A1 Novel antibodies for treatment and prevention of infection in animals and man |
06/30/1993 | EP0548178A1 Quantitative analysis and monitoring of protein structure by subtractive chromatography |
06/30/1993 | EP0548138A1 Methods of treating, diagnosing and monitoring therapies from levels of human oubain-like factor and antibody thereof |
06/30/1993 | CN1073719A Nanbv diagnostics and vaccines |
06/29/1993 | US5223605 Interleukin-4 binding protein-γ |
06/29/1993 | US5223487 Tri-, tetra-, penta- and hexapeptatides of Asp, Gly, Lys, Ser, Ala and salts |
06/29/1993 | US5223484 Dodecapeptide containing cysteine, histidine, arginine, lysine, glycine, tyrosine, alanine, aspartic acid, leucine |
06/29/1993 | US5223482 Polypeptide |
06/29/1993 | US5223441 Receptors for immune complexes |
06/29/1993 | US5223427 Synthetic polypeptide |
06/29/1993 | US5223426 Monoclonal antibodies reactive with defined regions of the t-cell antigen receptor |
06/29/1993 | US5223425 DNA sequence which codes serine protease for diagnosis and/or treatment of obesity or metabolic defects |
06/29/1993 | US5223417 Infecting with epstein-barr virus, transforming with activated ras gene |
06/29/1993 | US5223410 Method for production of antibodies utilizing an antigen-free animal |
06/29/1993 | US5223394 Recombinant dna molecule comprising lymphocyte function-associated antigen 3 phosphatidylinositol linkage signal sequence |
06/29/1993 | US5223392 Monoclonal antibodies against glycated albumin, hybrid cell lines producing these antibodies, and use therefore |
06/29/1993 | CA1319611C Purified hemoglobin solutions and method for making same |
06/24/1993 | WO1993012251A1 Senescent cell derived inhibitors of dna synthesis |
06/24/1993 | WO1993012248A1 Ligands and binding partner for treatment and diagnosis of inflammatory conditions |
06/24/1993 | WO1993012247A1 In vitro antibody production |
06/24/1993 | WO1993012246A1 Expression-secretion vectors for the production of biologically active fv fragments |
06/24/1993 | WO1993012232A1 Reactive neutralizing human anti-gp120 recombinant antibody, dna coding the same and use thereof |
06/24/1993 | WO1993012231A1 Composite antibodies of human subgroup iv light chain capable of binding to tag-72 |
06/24/1993 | WO1993012228A1 Method for generating structural and functional diversity in a peptide sequence |
06/24/1993 | WO1993012227A1 Transgenic non-human animals capable of producing heterologous antibodies |
06/24/1993 | WO1993012220A1 RECOMBINANT AND CHIMERIC ANTIBODIES TO c-erbB-2 |
06/24/1993 | WO1993012146A1 Trophoblast interferons and their use |
06/24/1993 | WO1993012144A1 ANTIBODY-MEDIATED REDUCTION OF α-KETOAMIDES |
06/24/1993 | WO1993012142A1 Cytokines with an unpaired cysteine residue and conjugates thereof |
06/24/1993 | WO1993012141A1 Nucleotide and protein sequences of the serrate gene and methods based thereon |
06/24/1993 | WO1993012136A1 Detection and treatment of acute leukemias resulting from chromosome abnormalities in the all-1 region |
06/24/1993 | WO1993012127A1 PLATELET GPIIIa P1?A1 AND P1A2¿ EPITOPES, THEIR PREPARATION AND USE |
06/24/1993 | WO1993011800A1 Bicycle-polyazamacrocyclocarboxylic acid complexes, conjugates, preparation and use as contrast agents |
06/24/1993 | WO1993011796A1 Further improvements relating to the radiolabelling of proteins |
06/24/1993 | WO1993011795A1 Anti-idiotypic vaccine for protection against bovine respiratory syncytial virus |
06/24/1993 | WO1993011794A1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
06/24/1993 | WO1993011790A1 Flea midgut-supernatant vaccines |
06/24/1993 | WO1993011782A1 Cetp inhibitor polypeptide, antibodies against the synthetic polypeptide and prophylactic and therapeutic anti-atherosclerosis treatments |
06/24/1993 | WO1993011781A1 Synthetic compounds and compositions with enhanced cell binding |
06/24/1993 | WO1993011778A1 Bifunctional antithrombotic molecules and antithrombotic polypeptides |
06/24/1993 | DE4142552A1 Monoklonale antikoerper gegen die typ i phospholipase a(pfeil abwaerts)2(pfeil abwaerts) als entzuendungshemmendes therapeutikum Monoclonal antibodies against type I phospholipase A (down arrow) 2 (down arrow) as therapeutic entzuendungshemmendes |
06/24/1993 | CA2125975A1 Further improvements relating to the radiolabelling of proteins |
06/24/1993 | CA2125767A1 Nucleotide and protein sequences of the serrate gene and methods based thereon |
06/24/1993 | CA2125396A1 Reactive neutralizing human anti-gp 120 recombinant antibody, dna coding the same and use thereof |
06/24/1993 | CA2125192A1 A process for generating a structural and functional diversity in a peptide sequence |
06/24/1993 | CA2125181A1 Trophoblast interferons and their use |
06/24/1993 | CA2124786A1 In vitro antibody production |
06/24/1993 | CA2124672A1 Cytokines with an upaired cysteine residue and conjugates thereof |
06/23/1993 | EP0547920A2 Recombinant thermostable DNA polymerase from archaebacteria |
06/23/1993 | EP0547631A2 Antibody expression vector and antibodies produced thereby |
06/23/1993 | EP0547446A2 Vaccines based on modified bovine herpesvirus type I |
06/23/1993 | EP0547201A1 Phagemide for screening antibodies |
06/23/1993 | EP0547200A1 Recombinant antibodies at the surface of e. coli |
06/23/1993 | EP0547172A1 REGULATION OF T-CELL PROLIFERATION VIA A NOVEL 5HT1a RECEPTOR |
06/23/1993 | EP0547163A1 Protein polyligands joined to a stable protein core |
06/23/1993 | EP0547137A1 Homoconjugated immunoglobulins |
06/23/1993 | EP0547076A1 Cd58-specific monoclonal antibodies and their use |
06/23/1993 | EP0547074A1 Human mitochondrial nad(p)?+ -dependent malate enzyme |
06/23/1993 | EP0547059A1 Pancreas-elastasis-1-specific antibody, a process for obtaining it and a test kit containing such antibodies. |
06/23/1993 | CN1021375C Enzyme immunoassay for detecting hiv antigens in human sera |
06/22/1993 | US5221789 Interferon-gamma receptor fragment and its production |
06/22/1993 | US5221740 Oxepane isomers of rapamycin useful as immunosuppressive agents |
06/22/1993 | US5221736 Sequential peptide and oligonucleotide syntheses using immunoaffinity techniques |
06/22/1993 | US5221683 Diaminopyridine compounds and methods of use |
06/22/1993 | US5221612 Unique protein marker for bladder cancer |
06/22/1993 | US5221611 Ddi immunoassays, derivatives, conjugates and antibodies |
06/18/1993 | EP0559834A4 Immunoassay and monoclonal antibodies useful for detecting truncated nerve growth factor receptor. |
06/16/1993 | EP0547029A1 Immunogen and its use for preparing antibodies to HbA1c |
06/16/1993 | EP0546634A2 Tumor associated monoclonal antibody 88BV59 |
06/16/1993 | EP0546149A1 Nucleotide sequences hybridizable with the nov gene of chickens |
06/16/1993 | EP0546126A1 Method and compositions for diagnosing and treating chronic fatigue immunodysfunction syndrome |
06/16/1993 | EP0546125A1 Osteogenic factor |
06/16/1993 | EP0546118A1 Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis |
06/16/1993 | EP0546110A1 New insulin-like growth factor binding protein igfbp-5 |
06/16/1993 | EP0546091A1 Homologous recombination in mammalian cells |
06/16/1993 | EP0546081A1 New insulin-like growth factor binding protein (igfbp-4) |
06/16/1993 | EP0546077A1 Cd18 peptide medicaments for the treatment of disease |
06/16/1993 | EP0546076A1 Use of anti-ICAM antibodies in the manufacture of a medicament FOR TREATING ENDOTOXIN SHOCK |
06/16/1993 | EP0546074A1 Genetic material encoding igfbp-5 |
06/16/1993 | EP0546054A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF |
06/16/1993 | EP0546053A1 Genetic material encoding igfbp-4 |
06/16/1993 | EP0545946A1 Growth-promoting agent |
06/16/1993 | EP0538412A4 A cdna encoding the rat d 1? dopamine receptor linked to adenylyl cyclase activation and expression product |
06/16/1993 | EP0406259B1 Antibodies, process for producing them, clones for the production of the antibodies, and use of the antibodies for diagnosis and therapy of tumours |
06/16/1993 | EP0308500B1 Human somatomedin carrier protein subunits and process for producing them |
06/16/1993 | CN1073264A Therapeutic and diagnostic methods based on tissue-specific NT-3 expression and receptor binding |
06/16/1993 | CN1073208A Hybridoma cell lines and their monoclonal antibodies to human pluripotent granulocyte colony stimulating factor |
06/16/1993 | CN1021257C Isolation of fetal cells from maternal blood to enable prenatal diagnosis |
06/15/1993 | US5219999 Immunoglobulin g and process for the production thereof |
06/15/1993 | US5219997 Monoclonal antibody which inhibits the adhesion functions of the β integrin, CR3 |
06/15/1993 | US5219996 Recombinant antibodies and methods for their production in which surface residues are altered to cysteine residues for attachment of effector or receptor molecules |
06/15/1993 | US5219991 Macrophage stimulating protein |
06/15/1993 | US5219837 Method of stimulating myelination of cells |
06/15/1993 | US5219749 Process for isolating and preparing purified chitin deacetylase |
06/15/1993 | US5219739 Wound healing agents |
06/15/1993 | US5219732 Antibody-mediated cofactor-driven reactions |
06/15/1993 | US5219725 Monoclonal antibodies to feline-t-lymphotropic lentivirus |
06/15/1993 | US5219579 Culture product of tumor tissue cells; cancer diagnosis, screening |
06/15/1993 | US5219578 Injecting immunoglobulin fraction obtained from serum of a goat free of artifically induced foreign antigens |
06/15/1993 | US5219566 Immunoprophylactic polypeptides for schistosomiasis |